PNV 2.52% $2.04 polynovo limited

Ann: PolyNovo's US FDA approval, page-19

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,829 Posts.
    lightbulb Created with Sketch. 76
    Yes, I agree with all the recent comments on my post, I think this is a company with a bright future. But my point is, it had a bright future last week at 18c, and in my mind it is no brighter today than it was then. Yes it now has FDA approval, but as the last poster pointed out this was "Expected" in Jan 2016. Thats only two trading days away, so this announcement should come as no great surprise.

    So the next catalyst for significant movement would be the signing up of the "Multinational Partner interested in US rights", with first sales in 2016. So between 1 and 12 months away then!

    Notwithstanding all of the above, I see from Commsec that the stock is now trading at 22c, which is probably a fair enough premium over last weeks price of 18c, given the removal of the risk around FDA approval.
 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
(20min delay)
Last
$2.04
Change
0.050(2.52%)
Mkt cap ! $1.398B
Open High Low Value Volume
$2.00 $2.05 $1.99 $1.625M 804.1K

Buyers (Bids)

No. Vol. Price($)
21 11779 $2.03
 

Sellers (Offers)

Price($) Vol. No.
$2.04 31084 22
View Market Depth
Last trade - 13.14pm 07/11/2024 (20 minute delay) ?
PNV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.